Antipyretic Drugs For Children Market Report 2026

Antipyretic Drugs For Children Market Overview

• Antipyretic Drugs For Children market size has reached to $3.4 billion in 2025 • Expected to grow to $4.61 billion in 2030 at a compound annual growth rate (CAGR) of 6.3% • Growth Driver: Rising Infections Drive Growth In Antipyretic Drugs For Children • Market Trend: Innovations in Children's Antipyretic Drugs For Gummy Formulations • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Antipyretic Drugs For Children Market?

Antipyretic drugs for children are medications used to reduce fever in children. They work by lowering the body's temperature through various mechanisms, such as inhibiting the production of fever-inducing substances. These drugs alleviate discomfort and prevent complications associated with high fever in children. The main drug classes of antipyretic drugs for children are acetaminophen, ibuprofen, and others. Acetaminophen is the alternative name for paracetamol, an analgesic and antipyretic medication for pain relief and fever reduction without anti-inflammatory properties. The various dosage forms include tablets, syrups, suppositories, and others for varying age groups, such as newborns, infants, toddlers, and children.

What Is The Antipyretic Drugs For Children Market Growth Forecast?

The antipyretic drugs for children market size is expected to see strong growth in the next few years. It will grow to $4.61 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to growth in pediatric population, rising self-care practices, expansion of pediatric otc products, increasing healthcare access, improved drug safety labeling. Major trends in the forecast period include rising incidence of pediatric fever cases, growing preference for liquid dosage forms, expansion of otc pediatric medications, increased parental awareness of fever management, higher demand for age-specific formulations.

Global Antipyretic Drugs For Children Market Segmentation

1) By Drug Class: Acetaminophen, Ibuprofen, Other Drug Classes 2) By Dosage Form: Tablets, Syrups, Suppositories, Other Dosage Forms 3) By Age Group: Newborns, Infants, Toddlers, Children

What Are The Drivers Of The Antipyretic Drugs For Children Market?

The growing number of viral and bacterial infections is expected to propel the growth of the antipyretic drugs for children market going forward. Viral infections refer to illnesses caused by viruses invading host cells, while bacterial infections are caused by harmful bacteria multiplying within the body. The incidence of viral and bacterial infections is increasing due to the resurgence of respiratory pathogens after the relaxation of pandemic restrictions. The antipyretic drugs for children market supports care management by providing fever-reducing medications that ease discomfort and prevent complications during pediatric infections. For instance, in March 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, the number of tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023, representing a rise of 1,295 cases. Therefore, the growing number of viral and bacterial infections is driving the growth of the antipyretic drugs for children industry. The growing birth rates are expected to propel the growth of the antipyretic drug for children market going forward. Birth rate is the number of live births per 1,000 people in a population per year. A growing birth rate is due to increased access to healthcare, improved economic conditions, and higher fertility rates in certain regions. A growing birth rate can increase the demand for antipyretic drugs for children, as a larger population of infants and young children requires more medical care, including fever management. For instance, in September 2024, according to the Registry of Births, Deaths, and Marriages, Victoria, an Australia-based electronic resource, the number of births registered in Victoria increased from 7,689 in July 2024 to 7,994 in August 2024. Therefore, growing birth rates are driving the antipyretic drug for children market.

Key Players In The Global Antipyretic Drugs For Children Market

Major companies operating in the antipyretic drugs for children market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol Myers Squibb, GlaxoSmithKline plc, Reckitt Benckiser Group, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Lupin Limited, Towa Pharmaceutical Co Ltd, Glenmark Pharmaceuticals Ltd., Alkem Laboratories Limited

Global Antipyretic Drugs For Children Market Trends and Insights

Major companies operating in the antipyretic drugs for children market are focusing on developing advanced drug formulations, such as medicine gummy bites that provide chewable, flavorful, and easy-to-administer dosage forms to improve compliance and comfort among young patients. Medicine gummy bites refer to child-friendly chewable formulations containing an accurately measured dose of an antipyretic agent (such as acetaminophen), designed to mask unpleasant taste, reduce swallowing difficulty, and simplify administration for caregivers while ensuring consistent therapeutic effect. For instance, in October 2023, DrKids, a US-based pharmaceutical company, launched an acetaminophen gummy bite, a child-friendly pain- and fever-relief alternative featuring an exact pre-measured dosing system for accurate administration, a palatable chewable gummy format that enhances acceptance, and a convenient design that supports safe, stress-free dosing for parents.

Regional Insights

North America was the largest region in the antipyretic drugs for children market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Antipyretic Drugs For Children Market?

The antipyretic drugs for children market consists of sales of acetaminophen (tylenol), ibuprofen (advil, motrin), and naproxen (aleve). Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Antipyretic Drugs For Children Market Report 2026?

The antipyretic drugs for children market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the antipyretic drugs for children industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.